Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Marco Del Chiaro

Concepts (599)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
183
2026
944
33.720
Why?
Pancreatectomy
84
2026
289
19.760
Why?
Carcinoma, Pancreatic Ductal
72
2026
297
17.510
Why?
Pancreaticoduodenectomy
36
2026
149
6.960
Why?
Adenocarcinoma
33
2026
927
6.870
Why?
Neoadjuvant Therapy
33
2026
475
6.760
Why?
Adenocarcinoma, Mucinous
18
2025
76
5.190
Why?
Mesenteric Veins
11
2025
28
4.930
Why?
Portal Vein
16
2026
123
4.200
Why?
Pancreas
41
2026
343
4.160
Why?
Carcinoma, Papillary
11
2025
83
2.930
Why?
Pancreatic Cyst
12
2025
50
2.770
Why?
Antineoplastic Combined Chemotherapy Protocols
19
2026
1998
2.560
Why?
Ampulla of Vater
8
2026
40
2.190
Why?
Common Bile Duct Neoplasms
7
2026
28
2.160
Why?
Pancreatic Fistula
11
2023
35
2.080
Why?
Retrospective Studies
101
2026
17438
2.040
Why?
Postoperative Complications
35
2026
3034
1.930
Why?
Aged
102
2026
26432
1.930
Why?
Humans
262
2026
146342
1.880
Why?
CA-19-9 Antigen
5
2026
36
1.850
Why?
Survival Rate
26
2026
2092
1.770
Why?
Pancreatic Ducts
10
2022
81
1.720
Why?
Middle Aged
110
2026
36619
1.650
Why?
Prognosis
33
2026
4351
1.620
Why?
Vascular Surgical Procedures
6
2025
352
1.550
Why?
Neoplasm Recurrence, Local
8
2026
1160
1.520
Why?
Exocrine Pancreatic Insufficiency
5
2019
25
1.500
Why?
Mesenteric Artery, Superior
5
2026
28
1.450
Why?
Chemotherapy, Adjuvant
17
2026
429
1.430
Why?
Gastrointestinal Neoplasms
2
2023
74
1.320
Why?
Male
126
2026
73396
1.310
Why?
Aged, 80 and over
46
2025
8391
1.300
Why?
Early Detection of Cancer
6
2021
506
1.300
Why?
Pancreas Transplantation
24
2010
70
1.230
Why?
Female
123
2026
79499
1.210
Why?
Treatment Outcome
44
2026
11821
1.100
Why?
Pancreatitis, Chronic
6
2020
64
1.070
Why?
Neoplasms, Cystic, Mucinous, and Serous
4
2025
27
1.020
Why?
Neoplasm Staging
15
2025
1488
1.000
Why?
Databases, Factual
4
2025
1493
0.990
Why?
Adult
77
2026
41087
0.940
Why?
Quality of Life
8
2025
3200
0.940
Why?
Anastomotic Leak
2
2025
46
0.930
Why?
Neoplasm Invasiveness
10
2026
504
0.920
Why?
Chyle
1
2025
4
0.920
Why?
Islets of Langerhans
5
2020
852
0.920
Why?
Carcinoma, Neuroendocrine
2
2023
38
0.910
Why?
Follow-Up Studies
24
2025
5439
0.910
Why?
Venous Thrombosis
2
2025
199
0.910
Why?
Endosonography
5
2021
160
0.900
Why?
Frozen Sections
1
2025
23
0.870
Why?
Cystadenocarcinoma, Mucinous
3
2026
12
0.870
Why?
Biomarkers, Tumor
14
2026
1339
0.870
Why?
Precancerous Conditions
3
2015
162
0.850
Why?
Nomograms
3
2022
59
0.850
Why?
Liver Neoplasms
4
2024
776
0.830
Why?
Hepatoblastoma
1
2024
52
0.800
Why?
Duodenal Neoplasms
3
2023
26
0.790
Why?
Thrombelastography
2
2024
182
0.780
Why?
Minimally Invasive Surgical Procedures
3
2020
196
0.710
Why?
Fluorouracil
11
2025
231
0.700
Why?
Leucovorin
8
2025
98
0.670
Why?
Surgical Stapling
1
2021
14
0.660
Why?
Absorbable Implants
1
2021
38
0.650
Why?
Risk Assessment
11
2025
3712
0.650
Why?
Incidence
11
2026
2936
0.650
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
228
0.650
Why?
Organ Transplantation
2
2023
244
0.630
Why?
Neoplasms, Second Primary
2
2019
103
0.630
Why?
Sweden
6
2025
114
0.620
Why?
Liver Transplantation
4
2024
751
0.610
Why?
Neoplasms, Multiple Primary
3
2015
57
0.610
Why?
Vascular Neoplasms
1
2020
19
0.610
Why?
Arteries
2
2019
261
0.610
Why?
Risk Factors
21
2026
10921
0.610
Why?
Adenocarcinoma, Papillary
2
2017
11
0.590
Why?
Deoxycytidine
9
2025
219
0.590
Why?
Pancreatitis
5
2022
146
0.590
Why?
Endocrine System Diseases
1
2019
35
0.590
Why?
Practice Guidelines as Topic
4
2026
1591
0.580
Why?
Neuroendocrine Tumors
4
2023
122
0.550
Why?
Neoplasm Metastasis
2
2025
693
0.530
Why?
Cohort Studies
12
2024
6077
0.520
Why?
Evidence-Based Medicine
5
2024
731
0.520
Why?
Living Donors
3
2016
216
0.510
Why?
Europe
8
2021
421
0.500
Why?
Patient Compliance
1
2021
589
0.500
Why?
Metabolomics
2
2019
738
0.490
Why?
Kidney Transplantation
17
2016
735
0.480
Why?
Prospective Studies
17
2026
8123
0.480
Why?
Hepatic Artery
4
2020
53
0.480
Why?
Patient Selection
9
2024
728
0.480
Why?
Celiac Artery
4
2020
19
0.470
Why?
Hepatitis B virus
1
2016
33
0.470
Why?
Pancreaticojejunostomy
3
2022
8
0.460
Why?
Watchful Waiting
1
2016
90
0.460
Why?
Disease Progression
6
2025
2867
0.450
Why?
Hypothermia, Induced
1
2016
96
0.440
Why?
Practice Patterns, Physicians'
4
2025
1408
0.430
Why?
Organ Sparing Treatments
1
2015
37
0.430
Why?
Pancreatic Diseases
3
2020
64
0.430
Why?
Survival Analysis
12
2024
1378
0.420
Why?
Adenoma
3
2025
210
0.420
Why?
Laparoscopy
4
2025
487
0.410
Why?
Postoperative Care
3
2026
301
0.410
Why?
Antineoplastic Agents
6
2021
2219
0.390
Why?
Radiotherapy, Adjuvant
2
2024
222
0.390
Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
218
0.390
Why?
Japan
5
2025
149
0.380
Why?
Clinical Trials as Topic
1
2018
1064
0.380
Why?
Cystadenocarcinoma
1
2013
4
0.380
Why?
Cystadenoma
1
2013
5
0.380
Why?
Combined Modality Therapy
5
2024
1271
0.380
Why?
Robotics
1
2014
89
0.380
Why?
Propensity Score
4
2026
376
0.370
Why?
Italy
11
2013
118
0.360
Why?
Cystadenoma, Serous
3
2020
18
0.360
Why?
Carcinoma, Hepatocellular
1
2016
370
0.360
Why?
Stomach Neoplasms
2
2024
128
0.360
Why?
Autoimmune Diseases
3
2021
467
0.350
Why?
Diabetes Mellitus
3
2019
1101
0.350
Why?
Tomography, X-Ray Computed
10
2021
2786
0.350
Why?
Diagnosis, Differential
8
2022
1503
0.350
Why?
Dilatation, Pathologic
3
2020
60
0.340
Why?
Peritoneal Neoplasms
2
2024
103
0.340
Why?
Lymphatic Metastasis
4
2026
335
0.340
Why?
Palliative Care
3
2019
1032
0.340
Why?
Benchmarking
3
2026
193
0.330
Why?
Cystadenoma, Mucinous
2
2026
11
0.330
Why?
Predictive Value of Tests
7
2025
2113
0.330
Why?
Risk
5
2022
920
0.320
Why?
Gastroenterology
2
2023
187
0.320
Why?
Gamma Rays
2
2021
56
0.320
Why?
Adolescent
17
2026
22557
0.320
Why?
Age Factors
7
2025
3347
0.310
Why?
Microbiota
3
2025
725
0.310
Why?
Portal System
6
2020
12
0.310
Why?
Chemoradiotherapy
2
2022
238
0.300
Why?
Neoplastic Syndromes, Hereditary
1
2010
47
0.300
Why?
Young Adult
13
2026
14330
0.300
Why?
Neoplasm Grading
4
2020
313
0.300
Why?
Time Factors
11
2024
7109
0.300
Why?
Magnetic Resonance Imaging
8
2021
3926
0.300
Why?
Tissue Donors
14
2005
425
0.290
Why?
Decision Making
1
2016
993
0.280
Why?
Kidney
2
2016
1498
0.280
Why?
Population Surveillance
2
2019
481
0.270
Why?
Tumor Burden
2
2022
326
0.270
Why?
Mass Screening
2
2019
1307
0.260
Why?
Software
2
2017
676
0.260
Why?
Graft Survival
12
2005
523
0.260
Why?
Margins of Excision
2
2025
55
0.250
Why?
Internationality
4
2020
156
0.250
Why?
Islets of Langerhans Transplantation
3
2020
72
0.250
Why?
Genetic Predisposition to Disease
6
2019
2488
0.240
Why?
Family Health
1
2007
194
0.240
Why?
Cytoreduction Surgical Procedures
2
2024
69
0.240
Why?
Disease-Free Survival
5
2023
778
0.240
Why?
Drainage
10
2022
187
0.240
Why?
Pedigree
3
2014
512
0.240
Why?
Intention to Treat Analysis
1
2026
78
0.230
Why?
Multidetector Computed Tomography
2
2016
40
0.230
Why?
Lymphocytes, Tumor-Infiltrating
2
2018
156
0.230
Why?
Prevalence
4
2025
2861
0.230
Why?
Observer Variation
2
2024
356
0.230
Why?
Immunohistochemistry
5
2019
1712
0.230
Why?
Pregnancy Complications, Neoplastic
1
2026
64
0.220
Why?
Cyst Fluid
2
2022
20
0.220
Why?
Pilot Projects
6
2026
1888
0.220
Why?
Netherlands
4
2026
85
0.220
Why?
Length of Stay
5
2021
1358
0.220
Why?
Diarrhea
1
2026
190
0.220
Why?
Postoperative Hemorrhage
1
2026
106
0.220
Why?
Symptom Assessment
1
2026
138
0.220
Why?
Cholangiocarcinoma
2
2024
110
0.220
Why?
Mucosal-Associated Invariant T Cells
1
2025
39
0.210
Why?
Pylorus
1
2024
17
0.210
Why?
Chemoradiotherapy, Adjuvant
3
2019
44
0.210
Why?
Proportional Hazards Models
4
2023
1331
0.210
Why?
Gallbladder Neoplasms
1
2024
20
0.210
Why?
Spheroids, Cellular
1
2025
81
0.200
Why?
Cell Transformation, Neoplastic
1
2026
314
0.200
Why?
Perioperative Care
2
2024
235
0.200
Why?
Lymph Node Excision
1
2024
174
0.190
Why?
Metastasectomy
1
2023
19
0.190
Why?
Incidental Findings
2
2021
81
0.190
Why?
Hyperemia
1
2023
49
0.190
Why?
Child, Preschool
6
2026
11913
0.190
Why?
Bile Duct Neoplasms
1
2024
132
0.180
Why?
Hospital Mortality
4
2020
1051
0.180
Why?
Surgical Oncology
1
2022
30
0.180
Why?
Hyperamylasemia
1
2022
3
0.180
Why?
Sensitivity and Specificity
3
2026
1998
0.180
Why?
Reoperation
7
2018
645
0.180
Why?
STAT3 Transcription Factor
2
2022
214
0.180
Why?
Pancreatitis, Acute Necrotizing
1
2022
14
0.180
Why?
Forecasting
1
2023
388
0.170
Why?
Colonic Neoplasms
1
2024
259
0.170
Why?
Carcinoma, Acinar Cell
1
2021
4
0.170
Why?
Bacteria
2
2025
766
0.170
Why?
Plastics
1
2022
50
0.170
Why?
Biliary Tract Surgical Procedures
1
2021
26
0.170
Why?
Pathology, Clinical
1
2021
29
0.170
Why?
Angiotensin Receptor Antagonists
1
2022
115
0.170
Why?
Datasets as Topic
1
2021
120
0.170
Why?
Cysts
1
2022
108
0.170
Why?
Multicenter Studies as Topic
1
2023
417
0.160
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
Surgical Mesh
1
2021
54
0.160
Why?
Fusobacterium nucleatum
1
2020
4
0.160
Why?
Fusobacterium Infections
1
2020
7
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.160
Why?
Body Composition
1
2024
689
0.160
Why?
United States
5
2025
16136
0.160
Why?
Albumins
3
2025
120
0.160
Why?
Surgeons
1
2025
351
0.160
Why?
Microdissection
2
2011
13
0.160
Why?
Digestive System Surgical Procedures
1
2021
115
0.160
Why?
Oligonucleotides, Antisense
1
2020
122
0.150
Why?
Blood
1
2020
107
0.150
Why?
Antimetabolites, Antineoplastic
2
2010
108
0.150
Why?
Quality Improvement
2
2026
1354
0.150
Why?
Antibodies, Bacterial
1
2020
147
0.150
Why?
Cyclosporine
4
2005
256
0.150
Why?
Myeloid-Derived Suppressor Cells
1
2020
78
0.150
Why?
Comorbidity
2
2022
1665
0.150
Why?
Paclitaxel
3
2025
260
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Conservative Treatment
1
2020
45
0.150
Why?
Lasers
2
2011
127
0.150
Why?
Dilatation
1
2019
73
0.150
Why?
Cystadenocarcinoma, Serous
1
2020
90
0.140
Why?
Biliary Tract Diseases
1
2019
32
0.140
Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
Why?
Bacterial Infections
1
2021
247
0.140
Why?
Laparotomy
2
2016
111
0.140
Why?
Bile Ducts
1
2019
66
0.140
Why?
Immunosuppressive Agents
6
2005
829
0.140
Why?
Organ Culture Techniques
1
2019
150
0.140
Why?
Mouth
1
2019
84
0.140
Why?
Elective Surgical Procedures
1
2020
216
0.140
Why?
Saliva
1
2020
256
0.140
Why?
Gene Expression Regulation, Neoplastic
4
2019
1432
0.140
Why?
Nutritional Support
1
2018
39
0.140
Why?
Fibrosis
1
2021
568
0.140
Why?
Iopamidol
2
2016
12
0.130
Why?
Recombinant Fusion Proteins
4
2005
663
0.130
Why?
DNA Damage
1
2021
439
0.130
Why?
Jejunum
2
2016
36
0.130
Why?
Patient Care Team
3
2020
701
0.130
Why?
Carcinoma
1
2019
225
0.130
Why?
Insulin
8
2013
2525
0.130
Why?
Societies, Medical
2
2020
907
0.130
Why?
DNA, Bacterial
1
2019
319
0.130
Why?
Referral and Consultation
1
2024
881
0.130
Why?
Preoperative Care
2
2026
396
0.130
Why?
Logistic Models
2
2020
2126
0.130
Why?
Surveys and Questionnaires
5
2025
6073
0.130
Why?
Kaplan-Meier Estimate
2
2016
970
0.130
Why?
Malnutrition
1
2018
87
0.130
Why?
Patient Acceptance of Health Care
1
2024
881
0.130
Why?
Radiosurgery
1
2020
398
0.120
Why?
Hepatic Duct, Common
1
2016
5
0.120
Why?
Analgesics, Opioid
1
2025
1221
0.120
Why?
Jaundice, Obstructive
1
2016
3
0.120
Why?
Biliary Tract Neoplasms
1
2016
30
0.120
Why?
Cross-Sectional Studies
3
2024
5899
0.120
Why?
Epitopes
1
2018
479
0.120
Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
24
0.120
Why?
Triiodobenzoic Acids
1
2016
6
0.120
Why?
Organ Preservation Solutions
3
2005
47
0.120
Why?
Cholangitis, Sclerosing
1
2016
56
0.120
Why?
Hyperglycemia
1
2020
384
0.120
Why?
Radiographic Image Enhancement
1
2016
57
0.110
Why?
Sex Factors
1
2022
2107
0.110
Why?
Cannabis
1
2023
521
0.110
Why?
Bacteriocins
1
2015
5
0.110
Why?
Hepatitis B
1
2016
66
0.110
Why?
Embolization, Therapeutic
1
2018
246
0.110
Why?
Genes, BRCA2
1
2015
33
0.110
Why?
Printing, Three-Dimensional
1
2016
102
0.110
Why?
Genes, BRCA1
1
2015
45
0.110
Why?
Interferon-gamma
1
2018
781
0.110
Why?
Pneumonia, Viral
1
2020
387
0.110
Why?
Coronavirus Infections
1
2020
379
0.110
Why?
Recovery of Function
1
2019
725
0.110
Why?
Papilloma, Intraductal
1
2014
1
0.110
Why?
Heredity
1
2014
13
0.110
Why?
Organ Preservation
3
2004
123
0.110
Why?
Machine Learning
1
2020
594
0.110
Why?
Diabetes Mellitus, Type 1
10
2010
3930
0.100
Why?
Membrane Proteins
1
2021
1130
0.100
Why?
Apoptosis
6
2021
2439
0.100
Why?
Germany
2
2024
139
0.100
Why?
Risk Adjustment
1
2014
86
0.100
Why?
Genomics
2
2017
853
0.100
Why?
Amylases
1
2013
18
0.100
Why?
Neoplasm, Residual
1
2014
143
0.100
Why?
High-Throughput Nucleotide Sequencing
1
2017
539
0.100
Why?
Tissue and Organ Harvesting
5
2005
69
0.100
Why?
MicroRNAs
2
2010
699
0.100
Why?
Virus Diseases
1
2016
219
0.100
Why?
Reproducibility of Results
6
2019
3416
0.100
Why?
Health Care Surveys
2
2025
541
0.100
Why?
North America
2
2024
300
0.100
Why?
Tacrolimus
2
2005
192
0.100
Why?
Severity of Illness Index
3
2019
2921
0.100
Why?
Perception
1
2016
373
0.100
Why?
Cell Proliferation
5
2021
2502
0.100
Why?
Antibodies, Monoclonal
4
2005
1512
0.100
Why?
Syndrome
1
2014
380
0.100
Why?
Abdomen
2
2004
142
0.100
Why?
Precision Medicine
1
2017
462
0.090
Why?
Cadaver
8
2005
304
0.090
Why?
Diagnostic Imaging
1
2015
340
0.090
Why?
Breast Neoplasms
2
2024
2418
0.090
Why?
Imaging, Three-Dimensional
1
2016
582
0.090
Why?
Diagnostic Errors
1
2014
178
0.090
Why?
Insulin-Secreting Cells
2
2007
393
0.090
Why?
ROC Curve
3
2024
617
0.090
Why?
Receptors, Antigen, T-Cell
1
2016
677
0.090
Why?
Immunotherapy, Adoptive
1
2016
356
0.090
Why?
Endoscopy
1
2014
316
0.090
Why?
Child
6
2026
22693
0.090
Why?
Catheter Ablation
1
2015
355
0.090
Why?
C-Reactive Protein
1
2013
429
0.080
Why?
Neoplasms
2
2022
2954
0.080
Why?
Loss of Heterozygosity
1
2011
51
0.080
Why?
Carcinoma in Situ
1
2011
45
0.080
Why?
Graft Rejection
5
2005
516
0.080
Why?
Biomarkers
1
2022
4340
0.080
Why?
Raffinose
3
2005
29
0.080
Why?
Kruppel-Like Transcription Factors
1
2011
83
0.080
Why?
Tissue and Organ Procurement
2
2004
305
0.080
Why?
Disaccharides
3
2005
21
0.080
Why?
Mannitol
3
2005
42
0.080
Why?
Glucose
3
2020
1053
0.080
Why?
Allopurinol
3
2005
70
0.080
Why?
Histidine
3
2005
67
0.080
Why?
Glutamates
3
2005
66
0.080
Why?
Electrolytes
3
2005
52
0.080
Why?
Lung Neoplasms
1
2023
2675
0.080
Why?
CD8-Positive T-Lymphocytes
1
2016
931
0.070
Why?
Duodenum
1
2010
76
0.070
Why?
Lymph Nodes
2
2024
511
0.070
Why?
Quality of Health Care
1
2014
702
0.070
Why?
Peptides
1
2015
992
0.070
Why?
Tumor Cells, Cultured
2
2021
882
0.070
Why?
Cell Line, Tumor
4
2025
3545
0.070
Why?
Down-Regulation
1
2011
614
0.070
Why?
Intra-Abdominal Fat
1
2009
104
0.070
Why?
Adenosine
3
2005
256
0.070
Why?
Glutathione
3
2005
369
0.070
Why?
Magnetic Resonance Angiography
1
2010
249
0.070
Why?
Enzyme Replacement Therapy
2
2018
15
0.070
Why?
T-Lymphocytes, Regulatory
2
2022
415
0.070
Why?
Feasibility Studies
2
2026
1135
0.070
Why?
Germ-Line Mutation
2
2019
180
0.060
Why?
Morbidity
2
2019
319
0.060
Why?
ErbB Receptors
1
2010
636
0.060
Why?
Gliclazide
1
2007
2
0.060
Why?
Consensus
2
2020
467
0.060
Why?
Diabetic Retinopathy
2
2006
211
0.060
Why?
Cytotoxicity, Immunologic
2
2018
224
0.060
Why?
Equilibrative Nucleoside Transporter 1
1
2006
19
0.060
Why?
Arterial Occlusive Diseases
1
2007
88
0.060
Why?
Extracorporeal Circulation
1
2006
15
0.060
Why?
Clinical Decision-Making
2
2020
365
0.060
Why?
Blood Loss, Surgical
1
2007
117
0.060
Why?
Pancreatic Pseudocyst
1
2025
18
0.060
Why?
Hepatic Veins
1
2006
28
0.060
Why?
C-Peptide
1
2007
191
0.060
Why?
Hepatectomy
2
2024
256
0.060
Why?
Lacerations
1
2006
38
0.060
Why?
Neovascularization, Pathologic
1
2007
287
0.060
Why?
Vena Cava, Inferior
1
2006
80
0.060
Why?
Tumor Microenvironment
2
2020
747
0.050
Why?
Smartphone
1
2026
103
0.050
Why?
Alcohol Drinking
2
2013
850
0.050
Why?
Smoking
2
2013
1486
0.050
Why?
Transplantation, Autologous
1
2006
306
0.050
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
30
0.050
Why?
Abdominal Injuries
1
2006
122
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
237
0.050
Why?
Drug Resistance, Neoplasm
1
2010
893
0.050
Why?
Bezoars
1
2004
4
0.050
Why?
Jehovah's Witnesses
1
2004
3
0.050
Why?
Succinimides
1
2024
21
0.050
Why?
Biopsy
3
2019
1075
0.050
Why?
Contrast Media
3
2016
493
0.050
Why?
Anthropometry
1
2024
204
0.050
Why?
Splenectomy
1
2024
61
0.050
Why?
Chemotaxis
1
2004
121
0.050
Why?
Intestinal Obstruction
1
2004
54
0.050
Why?
Cystectomy
1
2003
46
0.050
Why?
Mobile Applications
1
2026
196
0.050
Why?
RNA, Messenger
5
2011
2791
0.050
Why?
Antioxidants
1
2007
544
0.050
Why?
Intestine, Small
1
2004
160
0.050
Why?
Postoperative Period
2
2019
355
0.050
Why?
Ileum
1
2003
112
0.050
Why?
Intraoperative Complications
1
2004
157
0.050
Why?
Wounds, Nonpenetrating
1
2006
305
0.050
Why?
Propylamines
1
2022
11
0.050
Why?
Academic Medical Centers
1
2025
561
0.040
Why?
Delphi Technique
1
2024
350
0.040
Why?
Carbohydrates
1
2022
66
0.040
Why?
Patient Satisfaction
1
2026
706
0.040
Why?
Program Evaluation
1
2026
952
0.040
Why?
Genetic Testing
1
2005
492
0.040
Why?
Azathioprine
1
2001
43
0.040
Why?
Stents
2
2022
554
0.040
Why?
Patient Reported Outcome Measures
1
2026
516
0.040
Why?
Gastrectomy
1
2023
164
0.040
Why?
Creatinine
4
2004
511
0.040
Why?
Urinary Bladder
1
2003
194
0.040
Why?
Vascular Diseases
1
2004
252
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
974
0.040
Why?
Guideline Adherence
1
2025
594
0.040
Why?
Mycophenolic Acid
1
2001
117
0.040
Why?
Necrosis
1
2022
243
0.040
Why?
Retroperitoneal Space
3
2005
19
0.040
Why?
Ephrin-B2
1
2021
45
0.040
Why?
Hernia, Inguinal
1
2001
47
0.040
Why?
Steroids
1
2001
160
0.040
Why?
Endometriosis
1
2001
58
0.040
Why?
Hyperplasia
1
2021
164
0.040
Why?
Endoscopy, Gastrointestinal
1
2023
236
0.040
Why?
Urinary Bladder Neoplasms
1
2003
259
0.040
Why?
Microbial Viability
1
2021
83
0.040
Why?
Case-Control Studies
2
2022
3647
0.040
Why?
Diagnosis, Computer-Assisted
1
2020
92
0.040
Why?
Adipose Tissue
1
2024
642
0.040
Why?
Capecitabine
1
2019
56
0.040
Why?
Secretin
2
2010
6
0.040
Why?
Matched-Pair Analysis
1
2019
38
0.040
Why?
Republic of Korea
1
2019
43
0.040
Why?
Florida
1
2020
117
0.040
Why?
Medical Oncology
1
2022
345
0.040
Why?
Asia
1
2019
69
0.040
Why?
Mice, Inbred C57BL
2
2021
6034
0.040
Why?
Treatment Failure
3
2005
361
0.040
Why?
Mice
3
2022
18297
0.040
Why?
International Cooperation
1
2020
193
0.040
Why?
Patient Discharge
1
2026
997
0.040
Why?
Cell Death
1
2021
379
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2005
704
0.040
Why?
Cells, Cultured
3
2016
4118
0.040
Why?
Hyperthermia, Induced
1
2020
119
0.040
Why?
Area Under Curve
1
2019
335
0.040
Why?
Aquaporin 1
1
2018
3
0.040
Why?
Acute Disease
1
2022
1038
0.040
Why?
Mice, Nude
1
2020
668
0.040
Why?
Radiotherapy
1
2019
209
0.040
Why?
Pancreatic Elastase
1
2018
54
0.030
Why?
Stromal Cells
1
2019
123
0.030
Why?
Cause of Death
3
2005
456
0.030
Why?
Congresses as Topic
1
2020
226
0.030
Why?
Anastomosis, Roux-en-Y
2
2010
23
0.030
Why?
Multivariate Analysis
2
2013
1543
0.030
Why?
Hospitals, High-Volume
1
2018
51
0.030
Why?
Xenograft Model Antitumor Assays
1
2021
930
0.030
Why?
Preoperative Period
1
2018
157
0.030
Why?
Tumor Suppressor Protein p53
2
2017
530
0.030
Why?
Betacoronavirus
1
2020
288
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2010
752
0.030
Why?
Patient Safety
1
2020
352
0.030
Why?
Intestinal Neoplasms
1
2016
31
0.030
Why?
Registries
1
2025
2400
0.030
Why?
Diabetic Nephropathies
3
2005
320
0.030
Why?
Cell Movement
1
2021
951
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2017
250
0.030
Why?
Drug Therapy, Combination
3
2004
1036
0.030
Why?
Mass Spectrometry
1
2019
729
0.030
Why?
Principal Component Analysis
1
2016
192
0.030
Why?
Transplantation, Homologous
2
2010
416
0.030
Why?
Nutritional Status
1
2018
346
0.030
Why?
Robotic Surgical Procedures
1
2019
210
0.030
Why?
Anastomosis, Surgical
1
2016
164
0.030
Why?
Vitamins
1
2017
183
0.030
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
121
0.030
Why?
Cell Line
1
2021
2814
0.030
Why?
Research Design
1
2021
1143
0.030
Why?
Feces
1
2018
496
0.030
Why?
Anatomy, Cross-Sectional
1
2014
11
0.030
Why?
Flow Cytometry
1
2018
1163
0.030
Why?
Extracellular Matrix
1
2019
565
0.030
Why?
Radiation Dosage
1
2016
193
0.030
Why?
Animals
3
2022
38107
0.030
Why?
Intraoperative Care
1
2014
68
0.030
Why?
Antigens, Neoplasm
1
2016
271
0.030
Why?
Kidney Failure, Chronic
3
2004
589
0.020
Why?
Systemic Inflammatory Response Syndrome
1
2014
97
0.020
Why?
Dose-Response Relationship, Drug
2
2010
2022
0.020
Why?
Immunologic Memory
1
2016
369
0.020
Why?
Indole Alkaloids
1
2013
7
0.020
Why?
Drug Administration Schedule
2
2005
790
0.020
Why?
Cytokines
2
2016
2081
0.020
Why?
Drug Interactions
2
2005
405
0.020
Why?
Peptic Ulcer
1
2013
18
0.020
Why?
Pregnancy
1
2026
7230
0.020
Why?
Biomedical Research
1
2019
729
0.020
Why?
Histocompatibility Testing
2
2004
124
0.020
Why?
Algorithms
1
2020
1849
0.020
Why?
Asymptomatic Diseases
1
2013
102
0.020
Why?
Safety
2
2004
347
0.020
Why?
Lymphocyte Activation
1
2016
1137
0.020
Why?
Global Health
1
2015
403
0.020
Why?
Pandemics
1
2020
1707
0.020
Why?
Hypoxia
1
2019
1211
0.020
Why?
Infant
1
2025
10114
0.020
Why?
Carcinoma, Renal Cell
1
2013
231
0.020
Why?
In Situ Hybridization
1
2011
317
0.020
Why?
Korea
1
2010
18
0.020
Why?
Cell Growth Processes
1
2010
47
0.020
Why?
Matrix Metalloproteinase 2
1
2010
57
0.020
Why?
Randomized Controlled Trials as Topic
1
2017
1763
0.020
Why?
Odds Ratio
1
2013
1077
0.020
Why?
Microsatellite Repeats
1
2011
159
0.020
Why?
Biopsy, Needle
1
2010
183
0.020
Why?
Lung
1
2023
4122
0.020
Why?
Anti-Bacterial Agents
1
2021
1942
0.020
Why?
Matrix Metalloproteinase 9
1
2010
128
0.020
Why?
Pyridoxal Phosphate
1
2009
20
0.020
Why?
Edetic Acid
1
2009
47
0.020
Why?
Cardiovascular Diseases
1
2001
2219
0.020
Why?
PTEN Phosphohydrolase
1
2010
166
0.020
Why?
Thyroid Neoplasms
1
2013
380
0.020
Why?
Blood Glucose
3
2004
2360
0.020
Why?
Kidney Neoplasms
1
2013
419
0.020
Why?
Tetrazolium Salts
1
2008
18
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2010
441
0.020
Why?
Thiazoles
1
2008
139
0.020
Why?
Vascular Endothelial Growth Factor A
1
2010
545
0.020
Why?
Glyburide
1
2007
30
0.020
Why?
bcl-2-Associated X Protein
1
2007
53
0.020
Why?
Recurrence
1
2010
1133
0.020
Why?
Surgical Procedures, Operative
1
2010
307
0.010
Why?
Microscopy, Electron
1
2007
384
0.010
Why?
Deoxycytidine Kinase
1
2006
3
0.010
Why?
Epigenesis, Genetic
1
2011
712
0.010
Why?
Ribonucleoside Diphosphate Reductase
1
2006
6
0.010
Why?
Tyrosine
1
2007
217
0.010
Why?
Choledochostomy
1
2006
9
0.010
Why?
Motorcycles
1
2006
7
0.010
Why?
Budd-Chiari Syndrome
1
2006
5
0.010
Why?
Mutation
1
2017
4093
0.010
Why?
5'-Nucleotidase
1
2006
49
0.010
Why?
Cytidine Deaminase
1
2006
59
0.010
Why?
Prostatic Neoplasms
1
2013
972
0.010
Why?
Phosphorylation
1
2010
1724
0.010
Why?
Economics, Pharmaceutical
1
2005
10
0.010
Why?
Antilymphocyte Serum
1
2005
55
0.010
Why?
Fluorescein Angiography
1
2006
197
0.010
Why?
Methylprednisolone
1
2005
58
0.010
Why?
Fatal Outcome
1
2006
302
0.010
Why?
Blood Group Incompatibility
1
2005
21
0.010
Why?
Maximum Tolerated Dose
1
2005
217
0.010
Why?
Colorectal Neoplasms
1
2013
874
0.010
Why?
Isoantibodies
1
2005
58
0.010
Why?
Glycerolphosphate Dehydrogenase
1
2004
5
0.010
Why?
Fructose-Bisphosphate Aldolase
1
2004
10
0.010
Why?
Accidents, Traffic
1
2006
193
0.010
Why?
DNA Primers
1
2005
487
0.010
Why?
Proteomics
1
2011
1203
0.010
Why?
Hemorrhage
1
2010
825
0.010
Why?
Glucokinase
1
2004
15
0.010
Why?
Pyruvate Kinase
1
2004
29
0.010
Why?
Intraocular Pressure
1
2006
344
0.010
Why?
Tissue Culture Techniques
1
2004
82
0.010
Why?
Transcriptional Activation
1
2006
369
0.010
Why?
Pharmacogenetics
1
2005
176
0.010
Why?
Diabetic Neuropathies
1
2005
101
0.010
Why?
Renal Circulation
1
2004
75
0.010
Why?
Tumor Suppressor Proteins
1
2006
315
0.010
Why?
Monitoring, Physiologic
1
2005
279
0.010
Why?
Kidney Function Tests
1
2003
156
0.010
Why?
Carcinoma, Transitional Cell
1
2003
70
0.010
Why?
Visual Acuity
1
2006
499
0.010
Why?
Cell Separation
1
2004
300
0.010
Why?
In Vitro Techniques
1
2004
1041
0.010
Why?
Respiratory Insufficiency
1
2006
330
0.010
Why?
Base Sequence
1
2005
2123
0.010
Why?
Vulvar Diseases
1
2001
9
0.010
Why?
Thrombosis
1
2005
398
0.010
Why?
Immunoenzyme Techniques
1
2001
197
0.010
Why?
Obesity, Morbid
1
2005
287
0.010
Why?
Gene Expression
1
2006
1463
0.010
Why?
Glucocorticoids
1
2005
536
0.010
Why?
Ischemia
1
2004
421
0.010
Why?
Morphogenesis
1
2001
163
0.010
Why?
Hemodynamics
1
2004
1114
0.010
Why?
Neoplasm Proteins
1
2001
444
0.010
Why?
Blood Pressure
1
2005
1765
0.010
Why?
T-Lymphocytes
1
2005
2012
0.010
Why?
Body Mass Index
1
2004
2458
0.010
Why?
Hypoglycemic Agents
1
2005
1412
0.010
Why?
Infant, Newborn
1
2001
6460
0.000
Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)